Mobile and pervasive computing technologies and the future of Alzheimer's clinical trials.
Where this comes from
- Record sourced from PubMed, PMID 31304287.
- Also identified by DOI 10.1038/s41746-017-0008-y and PMC identifier 6550135.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The rapid growth of mobile phones, automated speech recognizing personal assistants, and internet access among the elderly provides new opportunities for incorporating such technologies into clinical research and personalized medical care. Alzheimer's disease is a good test case given the need for early detection, the high rate of clinical trial failures, the need to more efficiently recruit patients for trials, and the need for sensitive and ecologically valid trial outcomes.